H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY) Apr 1, 2026 06:59AM
Unicycive Therapeutics (UNCY) PT Raised to $22 at H.C. Wainwright Oct 29, 2025 06:49AM
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY) Jun 11, 2025 06:38AM
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY) Apr 11, 2025 06:38AM
Unicycive Therapeutics (UNCY) PT Raised to $7.50 at H.C. Wainwright Apr 1, 2025 06:46AM


Nov 12, 2024 07:52AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Oct 10, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Sep 4, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Aug 16, 2024 06:44AM Unicycive Therapeutics (UNCY) PT Lowered to $2.50 at H.C. Wainwright
Jul 11, 2024 10:32AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Jul 10, 2024 02:03PM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Oct 26, 2022 08:04AM Unicycive to Showcase Pipeline of Innovative Product Candidates at American Society of Nephrology’s Kidney Week 2022
Jul 19, 2022 06:11AM H.C. Wainwright Reiterates Buy Rating, $9 Price Target on Unicycive Therapeutics (UNCY)
Jun 8, 2022 06:04AM UPDATE: H.C. Wainwright Starts Unicycive Therapeutics (UNCY) at Buy